Randomized parallel controlled clinical trial of Qinpi Tongfeng decoction combined with bloodletting in the treatment of acute gouty arthritis (damp heat accumulation syndrome)

The First Teaching Hospital of Tianjin University of TCM0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•1. Accord with the diagnostic standard of Western medicine for acute gouty arthritis;
•2. Accord with the diagnostic standard of dampness heat accumulation syndrome of gout;
•3. The patient's disease was within 72 hours of acute gouty arthritis attack;
•4. The patient had gout at least once;
•5. Patients also need to have moderate, severe or extreme joint pain, using pain digital assessment scale score >= 4 points;
•6. Those who did not take other drugs for gouty arthritis within 72 hours before entering the group;
•7. Those who have not taken the anti uric acid drugs in recent 2 weeks;
•8. Aged from 18 to 70 years;
•9. The subjects agreed to join the study and signed the informed consent.

•1. Secondary gouty arthritis caused by renal failure, tumor chemotherapy or radiotherapy, drugs, etc;
•2. Patients with rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, knee osteoarthritis and other inflammatory arthritis diseases;
•3. The patient had multi joint gout (> 4 joints);
•4. Patients with severe primary diseases such as cardiovascular, cerebrovascular, pulmonary, renal, endocrine and hematopoietic systems;
•5. Alt, AST or Cr were more than 1.5 times ULN (upper limit of normal value);
•6. Allergic to the components of the test drug;
•7. Patients with asthma, urticaria or allergic reaction induced by taking aspirin or other non steroidal anti-inflammatory drugs;
•8. Pregnant, pregnant or lactating women;
•9. Patients with active peptic ulcer or bleeding, or patients with peptic ulcer or bleeding in the past;
•10. Those who have participated in or are participating in other clinical trials in recent one month;
•11. Mental illness, no insight, unable to express exactly or take medicine on time, unable to cooperate with the completion of the trial.

发起方

The First Teaching Hospital of Tianjin University of TCM